We provide hands-on CMC support to help you move from development data to a regulatory-ready story. This includes building a phase-appropriate CMC strategy, defining CQAs and a control strategy, and preparing structured inputs for IND/IMPD packages. We also support risk-based documentation (e.g., QRM/FMEA), justification of materials and critical process parameters, and alignment of analytical methods and stability-indicating assays with clinical-stage expectations
